Is viloxazine available in Canada yet, or is atomoxetine still the non-stimulant people can fill?

Viloxazine, known in the United States as Qelbree, is not on CADDRA's May 2026 Canadian ADHD medication chart, and it should not be described as a medicine you can fill at a Canadian pharmacy on the strength of US availability. Atomoxetine is the marketed SNRI-type non-stimulant on that chart, with a Health Canada ADHD indication that includes adults. Brand Strattera may no longer be manufactured; CADDRA lists atomoxetine, and generics exist. If the change is persistent, distressing, or affecting daily functioning, bring a brief timeline to the prescribing clinician rather than changing the dose independently. Related reading: https://www.fastreat.com/en/blogs/adhd-medication References: https://www.caddra.ca/wp-content/uploads/CADDRA_ADHD-Medication-Chart_May2026.pdf https://www.caddra.ca/wp-content/uploads/Canadian-ADHD-Practice-Guidelines-4.1-January-6-2021.pdf https://www.caddra.ca/medication-chart/